Oculus Innovative Sciences (OCLS)

Create an Alert
3.00 -0.01  -0.33%   NASDAQ Jun 19, 8:00PM BATS Real time Currency in USD

Oculus Innovative Sciences R&D Expense Quarterly:

0.669M for Dec. 31, 2012
View Full Chart

Oculus Innovative Sciences R&D Expense Quarterly Chart

    Oculus Innovative Sciences Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.669M
    Dec. 31, 2012 0.509M
    Sept. 30, 2012 0.513M
    June 30, 2012 0.532M
    March 31, 2012 0.476M
    Dec. 31, 2011 0.509M
    Sept. 30, 2011 0.56M
    June 30, 2011 0.436M
    March 31, 2011 0.63M
    Dec. 31, 2010 0.467M
    Sept. 30, 2010 0.553M
    June 30, 2010 0.396M
    March 31, 2010 0.32M
    Dec. 31, 2009 0.372M
       
    Sept. 30, 2009 0.583M
    June 30, 2009 0.721M
    March 31, 2009 0.631M
    Dec. 31, 2008 0.933M
    Sept. 30, 2008 2.15M
    June 30, 2008 2.321M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    OCLS R&D Expense Quarterly Benchmarks

    Companies
    AngioDynamics 5.793M
    Biolase 1.005M
    West Pharmaceutical Services 9.10M

    OCLS R&D Expense Quarterly Rankings

    Overall 89th percentile
    1697 of 16782
    Sector 62nd percentile
    524 of 1410 in Healthcare
    Industry 62nd percentile
    57 of 152 in Medical Instruments & Supplies

    OCLS R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.3200M Mar 2010
    Maximum 2.321M Jun 2008
    Average 0.7141M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');